文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期，新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

Psoriatic disease treatment nowadays: unmet needs among the "jungle of biologic drugs and small molecules".

作者信息

Megna Matteo, Balato Anna, Napolitano Maddalena, Gallo Lucia, Caso Francesco, Costa Luisa, Balato Nicola, Scarpa Raffaele

机构信息

Section of Dermatology, Department of Clinical Medicine and Surgery, University of Naples Federico II, Naples, Italy.

Department of Advanced Biomedical Sciences, Dermatology Unit, University of Naples Federico II, Naples, Italy.

出版信息

Clin Rheumatol. 2018 Jul;37(7):1739-1741. doi: 10.1007/s10067-018-4090-6. Epub 2018 Apr 11.

DOI:10.1007/s10067-018-4090-6
PMID:29644570
Abstract
摘要

相似文献

[1]
Psoriatic disease treatment nowadays: unmet needs among the "jungle of biologic drugs and small molecules".

Clin Rheumatol. 2018-7

[2]
Tailored treatment options for patients with psoriatic arthritis and psoriasis: review of established and new biologic and small molecule therapies.

Rheumatol Int. 2016-5

[3]
Current pharmacological treatment guidelines for psoriasis and psoriatic arthritis.

Expert Rev Clin Pharmacol. 2018-12-4

[4]
Induction of remission in biologic-naive, severe psoriasis and PsA with dual anti-cytokine combination.

Rheumatology (Oxford). 2021-7-1

[5]
Hyperlipidaemia in psoriatic disease: higher prevalence in psoriatic arthritis and inverse association with systemic therapy.

Rheumatology (Oxford). 2021-8-2

[6]
Intercepting psoriatic arthritis in patients with psoriasis: buy one get one free?

Ann Rheum Dis. 2022-1

[7]
Treatment of recalcitrant psoriasis and psoriatic arthritis with a combination of a biologic plus an oral JAK or TYK2 inhibitor: a case series.

Ann Rheum Dis. 2024-9-30

[8]
First-time prescriptions of biological disease-modifying antirheumatic drugs in rheumatoid arthritis, psoriatic arthritis and axial spondyloarthritis 2002-2011: data from the NOR-DMARD register.

Ann Rheum Dis. 2014-10

[9]
Biologics in psoriatic patients with malignancies: Where are we now? An Italian multicentric study.

J Eur Acad Dermatol Venereol. 2024-4

[10]
Physician perspectives in the management of psoriasis and psoriatic arthritis: results from the population-based Multinational Assessment of Psoriasis and Psoriatic Arthritis survey.

J Eur Acad Dermatol Venereol. 2015-10

引用本文的文献

[1]
First-in-Human Single and Multiple Ascending Dose Studies of Balinatunfib, a Small Molecule Inhibitor of TNFR1 Signaling in Healthy Participants.

Clin Pharmacol Ther. 2025-7

[2]
Effectiveness of secukinumab in patients with psoriasis and psoriatic arthritis in a Saudi real-world setting.

Adv Rheumatol. 2024-4-29

[3]
Long-term efficacy and safety of guselkumab in Chinese patients with moderate-to-severe plaque psoriasis.

Front Med (Lausanne). 2023-12-14

[4]
Injections Site Reactions and Biologics for Psoriasis: A Questionnaire Based Real Life Study.

Clin Cosmet Investig Dermatol. 2023-3-2

[5]
Eczematous eruption after brodalumab successfully treated with guselkumab and dupilumab.

Dermatol Ther. 2022-11

[6]
Bimekizumab for the Treatment of Psoriasis: A Review of the Current Knowledge.

Psoriasis (Auckl). 2022-6-8

[7]
Hepatitis Virus Reactivation in Patients with Psoriasis Treated with Secukinumab in a Real-World Setting of Hepatitis B or Hepatitis C Infection.

Clin Drug Investig. 2022-6

[8]
Risankizumab treatment in psoriasis patients who failed anti-IL17: A 52-week real-life study.

Dermatol Ther. 2022-7

[9]
Brodalumab Is Associated with High Rates of Complete Clearance and Quality of Life Improvement: A Subgroup Analysis of Patients with Psoriasis and Concomitant Psoriatic Arthritis.

Dermatology. 2022

[10]
Real world practice indirect comparison between guselkumab and risankizumab: Results from an Italian retrospective study.

Dermatol Ther. 2022-1

本文引用的文献

[1]
Guselkumab for the treatment of psoriasis.

Expert Opin Biol Ther. 2018-3-3

[2]
Psoriatic arthritis: tissue-directed inflammation?

Clin Rheumatol. 2018-2-23

[3]
Spondyloarthritis: Which composite measures to use in psoriatic arthritis?

Nat Rev Rheumatol. 2018-3

[4]
Metabolic syndrome in psoriatic arthritis: the interplay with cutaneous involvement. Evidences from literature and a recent cross-sectional study.

Clin Rheumatol. 2018-1-8

[5]
Switching Between Biological Treatments in Psoriatic Arthritis: A Review of the Evidence.

Drugs R D. 2017-12

[6]
Tofacitinib for Psoriatic Arthritis in Patients with an Inadequate Response to TNF Inhibitors.

N Engl J Med. 2017-10-19

[7]
Small molecule therapy for managing moderate to severe psoriatic arthritis.

Expert Opin Pharmacother. 2017-10

[8]
Psoriatic Disease 10 Years Later.

J Rheumatol. 2017-9

[9]
Evidence-based algorithm for diagnosis and assessment in psoriatic arthritis: results by Italian DElphi in psoriatic Arthritis (IDEA).

Reumatismo. 2016-12-16

[10]
Psoriatic arthritis and psoriasis: differential diagnosis.

Clin Rheumatol. 2016-8

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索